Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningLeukemiaHematopoietic Stem Cell TransplantationLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesHematologic NeoplasmsKidney TransplantationRecurrenceHematopoiesisCombined Modality TherapyMice, Inbred C57BLTreatment OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteRadiation ChimeraBone Marrow ExaminationImmunosuppressive AgentsTime FactorsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionHepatic Veno-Occlusive DiseaseBone RemodelingLeukemia, MyeloidBone Marrow NeoplasmsLymphoma, Non-HodgkinTransplantation ImmunologyGraft vs Host ReactionImmunosuppressionStem Cell TransplantationLymphocyte DepletionAcute DiseaseLeukocyte TransfusionRetrospective StudiesHeart TransplantationMyelodysplastic SyndromesT-LymphocytesSurvival AnalysisSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayHLA AntigensHematologic DiseasesLung TransplantationCyclosporineActuarial AnalysisBone DensityLymphocyte TransfusionFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyLymphomaOrgan TransplantationCell DifferentiationSurvival RateCarmustinePancytopeniaGraft vs Tumor EffectGraft vs Leukemia EffectLeukocyte CountCytarabineCytomegalovirus InfectionsMultiple MyelomaBone ResorptionSpleenMice, Inbred BALB CGranulocyte Colony-Stimulating FactorFlow CytometryDisease-Free SurvivalMelphalanEtoposidePrognosisFatal OutcomeCells, CulturedHodgkin DiseaseMice, KnockoutAntigens, CD34InfectionLymphoproliferative DisordersCord Blood Stem Cell TransplantationBone Neoplasms